ADC Therapeutics S.A. (ADCT) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

ADC Therapeutics S.A.

NYSE: ADCT · Real-Time Price · USD
3.40
0.11 (3.34%)
At close: Sep 04, 2025, 3:59 PM
3.40
-0.16%
After-hours: Sep 04, 2025, 06:22 PM EDT

ADC Therapeutics S.A. Revenue

ADC Therapeutics S.A. reported an annual revenue of $70.84M, reflecting a 1.84% growth. For the quarter ending June 30, 2025, ADC Therapeutics S.A. generated $18.84M in revenue.
Revenue (ttm)
70.84M
Revenue Growth
1.84%
Price / Sales Ratio
2.73
Revenue / Employee
269.34K
Employees
263
Market Cap
383.06M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 70.84M +1.84%
Dec 31, 2023 69.56M -66.86%
Dec 31, 2022 209.91M +518.89%
Dec 31, 2021 33.92M +Infinity%
Dec 31, 2020 0 -100.00%
Dec 31, 2019 2.34M +105.26%
Dec 31, 2018 1.14M -36.77%
Dec 31, 2017 1.8M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.